ClinicalTrials.Veeva

Menu

Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder

U

Utrecht Institute for Pharmaceutical Sciences

Status and phase

Completed
Phase 4

Conditions

ADHD

Treatments

Drug: methylphenidate

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The primary purpose of this study is to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients.

Full description

This study was set-up to examine the controversial issue whether or not it is safe to drive a car or not when treated with methylphenidate.

On-the-road driving tests during normal traffic are conducted to determine the effects of methylphenidate versus placebo on driving ability of adult ADHD patients.In addition, two laboratory tests are conducted to examine memory functioning and inhibitory control.

Sex

All

Ages

21 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult ADHD patient over 21 years old
  • valid driver's license for at least 3 years
  • treated with methylphenidate
  • written informed consent

Exclusion criteria

  • use of illicit drugs
  • use of drugs or having medical conditions known to affect driving ability

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems